REQUEST A DEMO
Total
USD $0.00
Search more companies

Deepar Pharmaceuticals Private Limited (India)

Main Activities: Other Chemical Product and Preparation Manufacturing
Full name: Deepar Pharmaceuticals Private Limited Profile Updated: May 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Deepar Pharmaceuticals Private Limited is an unlisted company, incorporated on 05/05/2016. It has its registered office in the State of Rajasthan, India. Company's corporate identification number (CIN) is U24290RJ2016PTC054843 and registration number is 054843. The company is a trade company, it is engaged in retail trading.

Legal Address
Basement, Plot No. 3/416, Chitrakoot Scheme, Sector-3, Ajmer Road
Jaipur; Rajasthan; Postal Code: 302021

Contact Details: Purchase the Deepar Pharmaceuticals Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Deepar Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Deepar Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
May 05, 2016
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Deepar Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-21.11%
Total operating revenue
-21.03%
Operating profit (EBIT)
1.55%
EBITDA
2.72%
Net Profit (Loss) for the Period
1.22%
Total assets
34.68%
Total equity
33.7%
Operating Profit Margin (ROS)
0.11%
Net Profit Margin
0.08%
Return on Equity (ROE)
-8.08%
Debt to Equity Ratio
-136.29%
Quick Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?